Benign Prostatic Hyperplasia affects nearly half of men by age 50 due to various factors somehow linked to aging rapidly. Traditional treatments like medications or surgery frequently entail side effects including dizziness or lengthy recoveries but the UroLift procedure offers minimally invasive solutions. FDA approved UroLift in 2013 for rapid symptom relief with minimal risks making it preferred by patients and urologists.
UroLift basically constitutes a minimally invasive surgical procedure. UroLift offers relief from urinary symptoms brought on by BPH through a relatively simple surgical intervention. Tiny implants lift enlarged prostate tissue away from urethra via intricate mechanisms, thus facilitating unobstructed urine flow. This method basically preserves prostate structure and gets rid of numerous complications that come with old school surgical procedures.
The procedure usually gets done pretty quickly under local anesthesia in the doctor's office. Patients often return home the same day bypassing lengthy hospital stays and unnecessary catheter deployments immediately afterwards.
1. Insertion of Implants: A special delivery device is inserted through the urethra to access the prostate.
2. Lifting Prostate Tissue: Small implants are deployed to lift and hold the obstructive prostate tissue away from the urethra.
3. Immediate Relief: Once the implants are in place, urine flow improves almost immediately as the urethra is widened.
The implants act like tie-backs for curtains, holding the prostate tissue permanently out of the way while maintaining its natural anatomy.
1. No Cutting or Removal of Tissue : UroLift uses small implants to gently lift and hold the enlarged prostate tissue out of the way, relieving pressure on the urethra. There’s no cutting, heating, or removal of tissue, which makes the procedure low-risk and much more comfortable than traditional surgery.
2. Rapid Relief from Urinary Symptoms : Most men notice significant improvement in BPH symptoms such as weak flow, frequent urination, or waking up at night to urinate—often within a few weeks, sometimes even sooner.
3. Preserves Sexual Function : Unlike medications or surgeries that may cause erectile dysfunction or retrograde ejaculation, UroLift is designed to preserve sexual function. Clinical studies show no impact on sexual desire or performance, which is a major concern for many men.
4. Outpatient Procedure with Quick Recovery : UroLift is performed as a day-care (OPD) procedure—no hospital stay needed. It typically takes about 15–20 minutes, and most patients return to normal activities within 2–3 days.
5. No Long-Term Medication Needed : It helps patients reduce or even stop reliance on daily BPH medications, which can have side effects like dizziness, fatigue, or sexual dysfunction. UroLift offers a drug-free solution for long-term symptom control.
6. No Catheter Required (in Most Cases) : Most men go home without a catheter after the procedure, avoiding the discomfort and inconvenience associated with catheter use common in other surgical treatments.
7. Long-Lasting Results : Clinical trials show that many men enjoy durable symptom relief for at least 5 years or more after undergoing UroLift. And if necessary, it doesn’t prevent future treatment options.
Embark on a journey of exceptional healthcare guided by industry's true luminaries who consistently exceed
expectations and set new benchmarks for excellence in everything from cutting-edge innovations to personalized care.
MASSH Hospital in Delhi distinguishes itself in providing UroLift treatments for benign prostatic hyperplasia (BPH) through several key factors:
1. Expert Medical Team: Led by Dr. Ankit Goel, the Head of the Department of Urology, Andrology, and Uro-Oncology, the hospital boasts a team of skilled urologists with extensive experience in advanced procedures like UroLift.
2. Minimally Invasive Techniques: MASSH specializes in minimal access surgeries, including UroLift, which involves inserting a small device through the urethra to lift and hold enlarged prostate tissue out of the way, thereby relieving urinary symptoms without cutting or removing prostate tissue.
3. Comprehensive Patient Care: The hospital emphasizes personalized care, tailoring treatment plans to each patient's unique needs, ensuring optimal outcomes and high patient satisfaction.
MASSH Group of Hospitals is a trusted name in delivering advanced healthcare solutions with a network of premier super speciality hospitals, committed to providing ethical, compassionate, and innovative care. Our expanding network ensures that cutting-edge medical services are always within your reach.
The procedure typically takes 15-30 minutes and is performed in an outpatient setting.
Most patients experience mild discomfort during and after the procedure. Local anesthesia is used, and any post-procedure discomfort is usually mild and resolves within a few days.
In most cases, a catheter is not required after the procedure. However, in rare cases, a temporary catheter may be needed for a short period.
Many patients notice improved urination within 1-2 weeks, with continued improvement over time.
The UroLift implants are permanent and designed to last a lifetime. Studies show long-lasting relief for at least 5-7 years, and possibly longer.
No. Unlike some other BPH treatments, UroLift preserves erectile and ejaculatory function.
Most patients resume normal activities within 2-3 days, though mild symptoms (such as urgency, slight burning, or mild blood in urine) may persist for a few weeks.
Common side effects include:
Yes, UroLift does not interfere with future BPH treatments or medications if needed later.
UroLift is FDA-approved and covered by Medicare and most private insurance plans. Coverage may vary, so check with your provider.
Yes. If needed, the implants can be removed, and other BPH treatments (like TURP or laser therapy) can still be performed.
Consult a urologist for an evaluation. Factors such as prostate size, symptom severity, and medical history will determine if UroLift is the best option for you.